$MRK
Merck & Co., Inc. Stock $mrk

$mrk Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024020283 Filed on May 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$16.11B	$15.78B	$14.49B
YoY Change	7.16%	8.89%	-8.89%
Cost Of Revenue	$3.073B	$2.961B	$3.352B
YoY Change	-12.82%	-11.66%	-37.7%
Gross Profit	$13.04B	$12.81B	$11.14B
YoY Change	13.28%	15.08%	5.84%
Gross Profit Margin	80.93%	81.23%	76.86%
Selling, General & Admin	$2.684B	$2.457B	$2.458B
YoY Change	2.25%	-0.04%	5.81%
% of Gross Profit	20.58%	19.17%	22.07%
Research & Development	$3.480B	$3.974B	$4.266B
YoY Change	-73.86%	-6.84%	65.61%
% of Gross Profit	26.69%	31.01%	38.31%
Depreciation & Amortization	$1.132B	$511.0M	$448.0M
YoY Change	25.36%	14.06%	6.41%
% of Gross Profit	8.68%	3.99%	4.02%
Operating Expenses	$6.164B	$6.431B	$6.724B
YoY Change	-61.32%	-4.36%	37.25%
Operating Profit	$6.875B	$6.383B	$4.411B
YoY Change	-255.3%	44.71%	-21.54%
Interest Expense	$49.00M	$116.0M	$429.0M
YoY Change	-125.26%	-72.96%	76.54%
% of Operating Profit	0.71%	1.82%	9.73%
Other Income/Expense, Net	-$108.0M	-$87.00M	-$503.0M
YoY Change	-668.42%	-82.7%	-28.95%
Pretax Income	$6.006B	$5.670B	$3.650B
YoY Change	-212.58%	55.34%	-24.91%
Income Tax	$545.0M	$903.0M	$825.0M
% Of Pretax Income	9.07%	15.93%	22.6%
Net Earnings	$5.455B	$4.762B	$2.821B
YoY Change	-191.3%	68.81%	-34.55%
Net Earnings / Revenue	33.86%	30.19%	19.47%
Basic Earnings Per Share	$2.15	$1.88	$1.11
Diluted Earnings Per Share	$2.14	$1.87	$1.11
COMMON SHARES
Basic Shares Outstanding	2.533B shares	2.533B shares	2.539B shares
Diluted Shares Outstanding	2.544B shares	2.544B shares	2.551B shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.35B	$5.619B	$10.39B
YoY Change	78.02%	-45.9%	16.34%
Cash & Equivalents	$11.30B	$5.579B	$9.707B
Short-Term Investments	$50.00M	$40.00M	$680.0M
Other Short-Term Assets	$8.740B	$7.950B	$6.737B
YoY Change	47.61%	18.01%	1.25%
Inventory	$6.469B	$6.510B	$5.863B
Prepaid Expenses
Receivables	$11.64B	$11.37B	$10.42B
Other Receivables	$764.0M	$744.0M	$0.00
Total Short-Term Assets	$38.21B	$31.45B	$33.40B
YoY Change	27.45%	-5.86%	7.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.22B	$23.05B	$21.76B
YoY Change	4.45%	5.92%	10.18%
Goodwill	$21.16B	$21.18B	$21.21B
YoY Change	-0.16%	-0.13%	-0.23%
Intangibles	$16.98B	$17.57B	$19.86B
YoY Change	-13.63%	-11.51%	-13.75%
Long-Term Investments	$1.571B	$1.527B	$2.232B
YoY Change	-43.59%	-31.59%	132.74%
Other Assets	$12.70B	$12.33B	$9.338B
YoY Change	47.42%	32.0%	-11.05%
Total Long-Term Assets	$74.43B	$74.40B	$74.39B
YoY Change	-0.09%	0.01%	-1.44%
TOTAL ASSETS
Total Short-Term Assets	$38.21B	$31.45B	$33.40B
Total Long-Term Assets	$74.43B	$74.40B	$74.39B
Total Assets	$112.6B	$105.8B	$107.8B
YoY Change	7.81%	-1.81%	1.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.519B	$3.514B	$3.680B
YoY Change	2.24%	-4.51%	-0.94%
Accrued Expenses	$13.99B	$13.13B	$13.00B
YoY Change	4.61%	0.97%	-7.48%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.071B	$3.077B	$2.672B
YoY Change	8.17%	15.16%	121.19%
Total Short-Term Liabilities	$26.06B	$25.10B	$23.13B
YoY Change	11.4%	8.51%	3.65%
LONG-TERM LIABILITIES
Long-Term Debt	$34.72B	$31.14B	$28.07B
YoY Change	1.89%	10.93%	-8.21%
Other Long-Term Liabilities	$7.329B	$8.262B	$8.244B
YoY Change	0.88%	0.22%	-15.38%
Total Long-Term Liabilities	$42.05B	$39.40B	$36.32B
YoY Change	1.72%	8.5%	-9.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.06B	$25.10B	$23.13B
Total Long-Term Liabilities	$42.05B	$39.40B	$36.32B
Total Liabilities	$68.11B	$64.50B	$59.45B
YoY Change	5.21%	8.5%	-5.1%
SHAREHOLDERS EQUITY
Retained Earnings	$60.19B	$56.70B	$62.04B
YoY Change	11.05%	-8.61%	10.29%
Common Stock	$46.15B	$46.39B	$46.26B
YoY Change	0.31%	0.28%	0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.58B	$40.36B	$46.83B
YoY Change
Total Liabilities & Shareholders Equity	$112.6B	$105.8B	$107.8B
YoY Change	7.81%	-1.81%	1.06%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$5.455B	$4.762B	$2.821B
YoY Change	-191.3%	68.81%	-34.55%
Depreciation, Depletion And Amortization	$1.132B	$511.0M	$448.0M
YoY Change	25.36%	14.06%	6.41%
Cash From Operating Activities	$5.637B	$3.090B	$1.339B
YoY Change	52.19%	130.77%	-71.88%
INVESTING ACTIVITIES
Capital Expenditures	$791.0M	$861.0M	$1.007B
YoY Change	-18.03%	-14.5%	-202.34%
Acquisitions		$746.0M	$0.00
YoY Change
Other Investing Activities	-$278.0M	$14.00M	-$37.00M
YoY Change	-97.35%	-137.84%	-79.67%
Cash From Investing Activities	-$1.069B	-$1.376B	-$2.359B
YoY Change	-90.66%	-41.67%	101.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$751.0M	$1.000M
YoY Change		75000.0%	-99.92%
Cash From Financing Activities	1.216B	-$2.814B	-$2.054B
YoY Change	-67.64%	37.0%	-33.44%
NET CHANGE
Cash From Operating Activities	5.637B	$3.090B	$1.339B
Cash From Investing Activities	-1.069B	-$1.376B	-$2.359B
Cash From Financing Activities	1.216B	-$2.814B	-$2.054B
Net Change In Cash	5.784B	-$1.238B	-$2.987B
YoY Change	-245.29%	-58.55%	-768.23%
FREE CASH FLOW
Cash From Operating Activities	$5.637B	$3.090B	$1.339B
Capital Expenditures	$791.0M	$861.0M	$1.007B
Free Cash Flow	$4.846B	$2.229B	$332.0M
YoY Change	76.93%	571.39%	-94.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2532806307	shares
CY2024Q1	us-gaap	Revenues Revenues	15775000000	usd
CY2023Q1	us-gaap	Revenues Revenues	14487000000	usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000310158
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q4	us-gaap	Hedged Liability Statement Of Financial Position Extensible Enumeration HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent
CY2024Q1	us-gaap	Hedged Liability Statement Of Financial Position Extensible Enumeration HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent
CY2024Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2023Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3540000000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3926000000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2483000000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2479000000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3992000000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4276000000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	123000000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	67000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-89000000	usd
CY2024Q1	mrk	Costs Expenses And Other CostsExpensesAndOther	10105000000	usd
CY2023Q1	mrk	Costs Expenses And Other CostsExpensesAndOther	10837000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5670000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3650000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	903000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	825000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	4767000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2825000000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3514000000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3922000000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14102000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15766000000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2398000000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2649000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	4762000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2821000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.88
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.87
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.11
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	4762000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2821000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	130000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-133000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	5000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	50000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-238000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	68000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-113000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-115000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4649000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2706000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5579000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6841000000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	40000000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	252000000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	80000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	88000000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11366000000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10349000000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	3413000000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	3348000000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6510000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6358000000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	7950000000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8368000000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	31445000000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	32168000000	usd
CY2024Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	280000000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	252000000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18620000000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18266000000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23045000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23051000000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	21181000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	21197000000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17572000000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18011000000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12326000000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11996000000	usd
CY2024Q1	us-gaap	Assets Assets	105849000000	usd
CY2023Q4	us-gaap	Assets Assets	106675000000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	3077000000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	1372000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	176000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	145000000	usd
CY2024Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	2008000000	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1985000000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	25099000000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25694000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	31142000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33683000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	922000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	871000000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8262000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8792000000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3577103522	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3577103522	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1788000000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1788000000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	44598000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	44509000000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	56697000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	53895000000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5274000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5161000000	usd
CY2024Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	97809000000	usd
CY2023Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	95031000000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1044402655	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1045470249	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	57445000000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	57450000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	40364000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	37581000000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	60000000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	54000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40424000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37635000000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	105849000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	106675000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	4767000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2825000000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	473000000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	543000000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	511000000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	448000000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	143000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	450000000	usd
CY2024Q1	mrk	Research And Development Asset Acquired Other Than Through Business Combination Written Off Asset Acquisition Two ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAssetAcquisitionTwo	656000000	usd
CY2023Q1	mrk	Research And Development Asset Acquired Other Than Through Business Combination Written Off Asset Acquisition Two ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAssetAcquisitionTwo	0	usd
CY2024Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	usd
CY2023Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	1192000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-51000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-277000000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-83000000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	197000000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	3382000000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2890000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3090000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1339000000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	861000000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1007000000	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	15000000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	562000000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	260000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	500000000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	746000000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2024Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	usd
CY2023Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	1327000000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	14000000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-37000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1376000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2359000000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	751000000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1950000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1853000000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	122000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	149000000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	87000000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-78000000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-81000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2814000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2054000000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-138000000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1238000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2987000000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	68000000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	79000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6909000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12773000000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	92000000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	79000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5671000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9786000000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	712000000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	246000000	usd
CY2024Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	99000000	usd
CY2024Q1	mrk	Restructuring Reserve Increase Decrease Noncash Activity RestructuringReserveIncreaseDecreaseNoncashActivity	-123000000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	736000000	usd
CY2024Q1	us-gaap	Hedged Liability Fair Value Hedge HedgedLiabilityFairValueHedge	1026000000	usd
CY2023Q4	us-gaap	Hedged Liability Fair Value Hedge HedgedLiabilityFairValueHedge	1056000000	usd
CY2024Q1	us-gaap	Hedged Liability Fair Value Hedge Cumulative Increase Decrease HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease	26000000	usd
CY2023Q4	us-gaap	Hedged Liability Fair Value Hedge Cumulative Increase Decrease HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease	56000000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	357000000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	167000000	usd
CY2024Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	32220000000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	342000000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	239000000	usd
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	30551000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	357000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	167000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	342000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	239000000	usd
CY2024Q1	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	111000000	usd
CY2024Q1	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	111000000	usd
CY2023Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	215000000	usd
CY2023Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	215000000	usd
CY2024Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	58000000	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	3000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2024Q1	us-gaap	Derivative Asset After Offset Subject To Master Netting Arrangement DerivativeAssetAfterOffsetSubjectToMasterNettingArrangement	188000000	usd
CY2024Q1	us-gaap	Derivative Liability After Offset Subject To Master Netting Arrangement DerivativeLiabilityAfterOffsetSubjectToMasterNettingArrangement	56000000	usd
CY2023Q4	us-gaap	Derivative Asset After Offset Subject To Master Netting Arrangement DerivativeAssetAfterOffsetSubjectToMasterNettingArrangement	124000000	usd
CY2023Q4	us-gaap	Derivative Liability After Offset Subject To Master Netting Arrangement DerivativeLiabilityAfterOffsetSubjectToMasterNettingArrangement	24000000	usd
CY2024Q1	us-gaap	Revenues Revenues	15775000000	usd
CY2023Q1	us-gaap	Revenues Revenues	14487000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-89000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-113000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-115000000	usd
CY2024Q1	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	113000000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	117000000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	117000000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	337000000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	337000000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	908000000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	764000000	usd
CY2024Q1	mrk	Debt Securitiesand Equity Securities Fvni DebtSecuritiesandEquitySecuritiesFVNI	1025000000	usd
CY2023Q4	mrk	Debt Securitiesand Equity Securities Fvni DebtSecuritiesandEquitySecuritiesFVNI	1101000000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	143000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	338000000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	851000000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	942000000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	4000000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	5000000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	1000000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	21000000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount	297000000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount	69000000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	354000000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	456000000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2000000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	14000000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	126000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	117000000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	226000000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	353000000	usd
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	30400000000	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	34200000000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	32000000000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	35100000000	usd
CY2024Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	2700000000	usd
CY2023	us-gaap	Accounts Receivable Sale AccountsReceivableSale	3000000000	usd
CY2024Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	58000000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	3000000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1902000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1954000000	usd
CY2024Q1	mrk	Inventory Work In Process And Raw Materials Excluding Supplies InventoryWorkInProcessAndRawMaterialsExcludingSupplies	8366000000	usd
CY2023Q4	mrk	Inventory Work In Process And Raw Materials Excluding Supplies InventoryWorkInProcessAndRawMaterialsExcludingSupplies	8037000000	usd
CY2024Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	276000000	usd
CY2023Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	277000000	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	10544000000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	10268000000	usd
CY2024Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	621000000	usd
CY2023Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	562000000	usd
CY2024Q1	mrk	Inventory Net And Inventory Noncurrent InventoryNetAndInventoryNoncurrent	9923000000	usd
CY2023Q4	mrk	Inventory Net And Inventory Noncurrent InventoryNetAndInventoryNoncurrent	9706000000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6510000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6358000000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	3413000000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	3348000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46058000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2821000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-115000000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.73
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1863000000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	149000000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-149000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46905000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37635000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	4762000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.77
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1960000000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	122000000	usd
CY2024Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-217000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40424000000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Settlements Plan Assets DefinedBenefitPlanSettlementsPlanAssets	21000000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Benefit Obligation Increase Decrease For Remeasurement Due To Settlement DefinedBenefitPlanBenefitObligationIncreaseDecreaseForRemeasurementDueToSettlement	-44000000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	73000000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	112000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	303000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	242000000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-83000000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-61000000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	143000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	450000000	usd
CY2024Q1	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-160000000	usd
CY2023Q1	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-115000000	usd
CY2024Q1	mrk	Other Nonoperating Income Expense Other OtherNonoperatingIncomeExpenseOther	43000000	usd
CY2023Q1	mrk	Other Nonoperating Income Expense Other OtherNonoperatingIncomeExpenseOther	-463000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-89000000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	217000000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	208000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.159
CY2024Q1	mrk	Effective Income Tax Rate Reconciliation Unfavorable Discrete Impact Percent EffectiveIncomeTaxRateReconciliationUnfavorableDiscreteImpactPercent	0.016
CY2024Q1	mrk	Tax Benefit Resulting From Acquisition Charge TaxBenefitResultingFromAcquisitionCharge	0	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.226
CY2023Q1	mrk	Effective Income Tax Rate Reconciliation Unfavorable Discrete Impact Percent EffectiveIncomeTaxRateReconciliationUnfavorableDiscreteImpactPercent	0.055
CY2023Q1	mrk	Tax Benefit Resulting From Acquisition Charge TaxBenefitResultingFromAcquisitionCharge	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4762000000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4762000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2821000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2821000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2533000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2538000000	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11000000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13000000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2544000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2551000000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.88
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.87
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.11
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q1	us-gaap	Revenues Revenues	15775000000	usd
CY2023Q1	us-gaap	Revenues Revenues	14487000000	usd
CY2024Q1	mrk	Increase Decrease In Hedge Revenue IncreaseDecreaseInHedgeRevenue	54000000	usd
CY2023Q1	mrk	Increase Decrease In Hedge Revenue IncreaseDecreaseInHedgeRevenue	99000000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	61000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	51000000	usd
CY2024Q1	mrk	Sales Discounts SalesDiscounts	3200000000	usd
CY2023Q1	mrk	Sales Discounts SalesDiscounts	3100000000	usd
CY2024Q1	us-gaap	Revenues Revenues	15775000000	usd
CY2023Q1	us-gaap	Revenues Revenues	14487000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5670000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3650000000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-020283-index-headers.html	Edgar Link	pending
0001628280-24-020283-index.html	Edgar Link	pending
0001628280-24-020283.txt	Edgar Link	pending
0001628280-24-020283-xbrl.zip	Edgar Link	pending
exhibit311-rule13ax14a15dx.htm	Edgar Link	pending
exhibit312-rule13ax14a15dx.htm	Edgar Link	pending
exhibit321-section1350cert.htm	Edgar Link	pending
exhibit322-section1350cert.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mrk-20240331.htm	Edgar Link	pending
mrk-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mrk-20240331_cal.xml	Edgar Link	unprocessable
mrk-20240331_def.xml	Edgar Link	unprocessable
mrk-20240331_lab.xml	Edgar Link	unprocessable
mrk-20240331_pre.xml	Edgar Link	unprocessable
mrk-20240331_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRK
Merck & Co., Inc. Stock $mrk

2024 Q2 Form 10-Q Financial Statement

#000162828024020283 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRK Merck & Co., Inc. Stock $mrk

2024 Q2 Form 10-Q Financial Statement

#000162828024020283 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRK
Merck & Co., Inc. Stock $mrk